A phase 1 study of the CDK9 inhibitor voruciclib in relapsed/refractory acute myeloid leukemia and B-cell malignancies
CDK9抑制剂voruciclib治疗复发/难治性急性髓系白血病和B细胞恶性肿瘤的I期研究
期刊:Blood Advances
影响因子:7.1
doi:10.1182/bloodadvances.2024014633
Davids, Matthew S; Brander, Danielle M; Alvarado-Valero, Yesid; Diefenbach, Catherine S; Egan, Daniel N; Dinner, Shira N; Javidi-Sharifi, Nathalie; Al Malki, Monzr M; Begna, Kebede H; Bhatt, Vijaya Raj; Abedin, Sameem; Cook, Rachel J; Collins, Mary C; Roleder, Carly; Dominguez, Edward C; Rajagopalan, Prabhu; Wiley, Sandra E; Ghalie, Richard G; Danilov, Alexey V
B细胞
肿瘤
CDK9
肿瘤免疫
白血病
细胞生物学
免疫/内分泌
